PHR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026

A federal securities class action has been filed against Phreesia, Inc. (NYSE: PHR) alleging that the company and its executives made false and misleading statements about growth opportunities while concealing slowing demand and weakening pharmaceutical marketing commitments. After Phreesia announced significantly reduced revenue guidance on March 30, 2026, the stock price fell approximately 27% from $11.41 to $8.38 per share. Investors who purchased PHR stock between May 8, 2025 and March 30, 2026 have until July 13, 2026 to seek lead plaintiff appointment.